rivaroxaban granule
NDC 70748-355, rivaroxaban granule, for suspension, from Lupin Pharmaceuticals, Inc..
- Product NDC
- 70748-355
- Status
- Listed
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218195
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70748-355 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIVAROXABAN155 mg/1
Pharmacologic classes
Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70748-355-01 | 70748035501 | 1 BOTTLE in 1 CARTON (70748-355-01) / 1 FOR SUSPENSION in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b0306b06-d8cf-48de-9e93-57d77e4e98f5NADAC price for package 70748035501
GET /v1/drugs/nadac/70748035501
Use it
Look up 70748-355 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70748-355 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70748-355. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.